(Q40194625)

https://doi.org/10.1016/j.steroids.2023.109237

18 September 2017

1 reference

29 December 2023

title

Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (English)

1 reference

18 September 2017

0 references

1 reference

Hung-Yun Lin

1

1 reference

18 September 2017

Heng-Yuan Tang

2

1 reference

18 September 2017

Ai Shih

3

1 reference

18 September 2017

Travis Keating

4

1 reference

18 September 2017

Gary Cao

5

1 reference

18 September 2017

Paul J Davis

6

1 reference

18 September 2017

Faith B Davis

7

1 reference

18 September 2017

publication date

15 December 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

72

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

180-187

1 reference

Differences between the effects of thyroxine and tetraiodothyroacetic acid on TSH suppression and cardiac hypertrophy

18 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Enhancement by thyroxine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

VEGF-integrin interplay controls tumor growth and vascularization.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid subjects

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.STEROIDS.2006.11.014

Identifiers

DOI

10.1016/J.STEROIDS.2006.11.014

1 reference

18 September 2017

1 reference